ARTICLE | Distillery Therapeutics
Cancer
September 13, 2017 5:07 PM UTC
Patient sample, cell culture and mouse studies suggest immunotherapies targeting GPC2 could help treat neuroblastomas expressing the antigen. In neuroblastoma patients, high levels of GPC2 in tumor sa...
BCIQ Company Profiles
BCIQ Target Profiles